Clinical Trials Logo
  1. Home
  2. Hearing Loss, Cochlear
  3. NCT02948790

Auditory Nerve Monitoring Using Intra-cochlear Stimulation in Subjects With Acoustic Neuroma — NeuriStim  

Hearing Loss, Cochlear Clinical Trial

Official title:
Auditory Nerve Monitoring Using Intra-cochlear Stimulation in Subjects With Acoustic Neuroma : Feasibility Study

Clinical Trial Summary

The aim of this study is to assess the auditory nerve functionality with an intraoperative approach following a surgical removal of acoustic neuroma in patients with severe to profound sensorineural hearing disabilities.

Clinical Trial Description

Whatever the acoustic neuroma treatments, the patient risks a hearing loss. The global strategy of hearing care aims to preserve the quality of life and patient hearing. For severe to profound hearing loss and anatomical auditory nerve preservation, the cochlear implant is put forward compared to the auditory brainstem implant. Indeed, cochlear implant provides better speech outcomes. If cochlear implantation is not possible or no benefit for the patient, the brainstem implant is the most widely used. The Neuristim device is used to investigate the auditory nerve integrity following neuroma surgery or on an affected auditory nerve. The Neuristim is an intra-cochlear stimulator used in an intraoperative way. The intra-cochlear electrodes provide an electrical stimulation to auditory nerve fibers, and auditory nerve response measurements to these electrical stimulation are recorded and evaluated to determine the auditory nerve functionality. The Neuristim is a device for helping surgeons to choose the most appropriate implantable solution. 2 groups of patients will be involved in this study: - a group of 17 patients with an acoustic neuroma or a past neuroma surgically removed or acoustic neuroma not requiring a surgery and with severe to profound hearing loss candidate for a cochlear implant or a auditory brainstem depending on the auditory nerve functionality, - a group of 17 patients with severe to profound hearing loss candidate for a cochlear implant. ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details
NCT number NCT02948790
Study type Interventional
Source Oticon Medical
Contact
Status Completed
Phase N/A
Start date April 7, 2017
Completion date April 3, 2019
View Details
See also
  Status Clinical Trial Phase
Completed NCT04222296 - Bimodal, CROS and Severe Profound Hearing Loss Study N/A
Recruiting NCT04130113 - Expanded Indications in the MED-EL Pediatric Cochlear Implant Population N/A
Completed NCT05052944 - Single-sided Deafness and Cochlear Implantation
Terminated NCT05586555 - A Monocentric Study Evaluating Pupillometry as an Objective Measurement for CI Fittings N/A
Not yet recruiting NCT06424262 - Performance and Hearing-related Outcomes in Adults Implanted With the CI622D Dexamethasone-eluting Cochlear Implant Compared to Those Implanted With a Standard Cochlear Implant (CI622) N/A
Recruiting NCT05474963 - Sudden Sensorineural Hearing Loss in Wonju Severance Christian Hospital
Not yet recruiting NCT03101917 - Microtable® Method for Cochlear Implantation Investigational Device Exemption (IDE) N/A
Recruiting NCT03848338 - Electrocochleography Function for Monitoring Residual Hearing N/A
Not yet recruiting NCT06218966 - Usability of the Intracochlear Catheter INCAT - a Feasibility Study N/A
Completed NCT06326866 - Otoacoustic Emissions in Different Blood Types
Completed NCT02941627 - The Neuro Zti Cochlear Implant System Efficacy and Safety in Adults N/A
Completed NCT05237180 - Evaluation of the Effect of a Spatial Localization Training Program on Auditory Comprehension N/A
Completed NCT04010721 - Effects of Pulses on Loudness N/A
Recruiting NCT04919928 - Benefits From Bimodal Fittings With Cochlear Implant and Hearing Aid vs Bilateral Hearing Aids N/A
Recruiting NCT04724265 - Cytomegalovirus (CMV) Perilymphatic Fluid N/A
Withdrawn NCT04357704 - Improved Speech Recognition Performance in Noise by Encoding Binaural Spatial Cues to the Cochlea Implant User N/A